Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Cincinnati, OH
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Columbus, OH
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated:  9/23/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated: 9/23/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated:  9/23/2015
Research Site
mi
from
Quilmes,
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of Low Dose BAY58-2667 (25 µg/h, 10 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Status: Enrolling
Updated: 9/23/2015
Research Site
mi
from
Quilmes,
Click here to add this to my saved trials
Remote Ischemic Preconditioning in Cardiac Surgery Trial
Remote Ischemic Preconditioning in Cardiac Surgery: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  9/24/2015
Maine Medical Centre
mi
from
Portland, ME
Remote Ischemic Preconditioning in Cardiac Surgery Trial
Remote Ischemic Preconditioning in Cardiac Surgery: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 9/24/2015
Maine Medical Centre
mi
from
Portland, ME
Click here to add this to my saved trials
Remote Ischemic Preconditioning in Cardiac Surgery Trial
Remote Ischemic Preconditioning in Cardiac Surgery: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  9/24/2015
Wake Forest
mi
from
Winston-Salem, NC
Remote Ischemic Preconditioning in Cardiac Surgery Trial
Remote Ischemic Preconditioning in Cardiac Surgery: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 9/24/2015
Wake Forest
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Remote Ischemic Preconditioning in Cardiac Surgery Trial
Remote Ischemic Preconditioning in Cardiac Surgery: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  9/24/2015
University of Calgary
mi
from
Calgary,
Remote Ischemic Preconditioning in Cardiac Surgery Trial
Remote Ischemic Preconditioning in Cardiac Surgery: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 9/24/2015
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
Status: Enrolling
Updated:  9/25/2015
Maimonides Medical Center
mi
from
Brooklyn, NY
Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
Status: Enrolling
Updated: 9/25/2015
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dyskinesia, Heterotaxy and Congenital Heart Disease
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia With Heterotaxy and Complex Congenital Heart Disease
Status: Enrolling
Updated:  9/26/2015
Childrens National Medical Center
mi
from
Washington,
Dyskinesia, Heterotaxy and Congenital Heart Disease
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia With Heterotaxy and Complex Congenital Heart Disease
Status: Enrolling
Updated: 9/26/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Dyskinesia, Heterotaxy and Congenital Heart Disease
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia With Heterotaxy and Complex Congenital Heart Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Dyskinesia, Heterotaxy and Congenital Heart Disease
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia With Heterotaxy and Complex Congenital Heart Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities
Evaluation and Treatment of Patients With Spinal Vascular Abnormalities
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities
Evaluation and Treatment of Patients With Spinal Vascular Abnormalities
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Abnormal Blood Clotting in Children With Stroke
Study of Abnormal Acquired and Genetic Coagulation Factors in Children With Porencephaly and Stroke
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Study of Abnormal Blood Clotting in Children With Stroke
Study of Abnormal Acquired and Genetic Coagulation Factors in Children With Porencephaly and Stroke
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Identification and Treatment of Feeder Vessels in Macular Degeneration
Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration
Status: Enrolling
Updated:  9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Identification and Treatment of Feeder Vessels in Macular Degeneration
Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration
Status: Enrolling
Updated: 9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting
Assessing the Risk of New Ischemic Brain Lesions With On- Versus Off-Pump Coronary Artery Bypass Grafting
Status: Enrolling
Updated:  9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting
Assessing the Risk of New Ischemic Brain Lesions With On- Versus Off-Pump Coronary Artery Bypass Grafting
Status: Enrolling
Updated: 9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Biological Markers in Retinal Vasculitis
Identification of Biological Markers in Retinal Vasculitis
Status: Enrolling
Updated:  9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Biological Markers in Retinal Vasculitis
Identification of Biological Markers in Retinal Vasculitis
Status: Enrolling
Updated: 9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins
Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis With Low Dose Recombinant Tissue Plasminogen Activator Plus Anticoagulation
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins
Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis With Low Dose Recombinant Tissue Plasminogen Activator Plus Anticoagulation
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Framingham Study: Examining DNA Markers and Links to Diseases
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Framingham Study: Examining DNA Markers and Links to Diseases
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated:  9/26/2015
Baptist Health System, Inc.
mi
from
Birmingham, AL
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated: 9/26/2015
Baptist Health System, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated:  9/26/2015
University of Wisconsin
mi
from
Madison, WI
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated: 9/26/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema
Status: Enrolling
Updated:  9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema
Status: Enrolling
Updated: 9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Biomarkers for Cardiovascular Disease
Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Biomarkers for Cardiovascular Disease
Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis
Prospective Study of Inflammatory Markers and Genes as Predictors of Atherosclerotic Cardiovascular Disease in Dialysis Patients
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis
Prospective Study of Inflammatory Markers and Genes as Predictors of Atherosclerotic Cardiovascular Disease in Dialysis Patients
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Genetic Analysis of Left-Right Axis Formations
Genetic Analysis of Left-Right Axis Malformations
Status: Enrolling
Updated:  9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Analysis of Left-Right Axis Formations
Genetic Analysis of Left-Right Axis Malformations
Status: Enrolling
Updated: 9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Status: Enrolling
Updated:  9/26/2015
Mid-Atlantic Associates
mi
from
Baltimore, MD
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Status: Enrolling
Updated: 9/26/2015
Mid-Atlantic Associates
mi
from
Baltimore, MD
Click here to add this to my saved trials
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Catheter-Based Treatment of Cardiovascular Disease
Catheter-Based Treatment of Cardiovascular Disease in Patients
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Catheter-Based Treatment of Cardiovascular Disease
Catheter-Based Treatment of Cardiovascular Disease in Patients
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Validation of MRI Measurement of Cardiac Blood Flow
Validation of Cardiac MR Perfusion With Cardiac Catheterization Physiological Assessment
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Validation of MRI Measurement of Cardiac Blood Flow
Validation of Cardiac MR Perfusion With Cardiac Catheterization Physiological Assessment
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Imaging of Totally Blocked Arteries
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Imaging of Totally Blocked Arteries
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genes Causing Ebstein's Anomaly
Genes Causing Congenital Ebstein's Anomaly
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genes Causing Ebstein's Anomaly
Genes Causing Congenital Ebstein's Anomaly
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genes Causing Ebstein's Anomaly
Genes Causing Congenital Ebstein's Anomaly
Status: Enrolling
Updated:  9/26/2015
Republican Scientific and Clinical Cardiology Center
mi
from
Republic of Belarus,
Genes Causing Ebstein's Anomaly
Genes Causing Congenital Ebstein's Anomaly
Status: Enrolling
Updated: 9/26/2015
Republican Scientific and Clinical Cardiology Center
mi
from
Republic of Belarus,
Click here to add this to my saved trials
Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia With Neovascularization (MACTEL 1)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia With Neovascularization (MACTEL 1)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia Without Neovascularization (MACTEL 2)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia Without Neovascularization (MACTEL 2)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy
Long Term Follow Up of Children and Adolescents Diagnosed With Hypertrophic Cardiomyopathy: Identification of Risk Factors That Predict Arrhythmia Events
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy
Long Term Follow Up of Children and Adolescents Diagnosed With Hypertrophic Cardiomyopathy: Identification of Risk Factors That Predict Arrhythmia Events
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Roles of Trust and Respect in Patient Reactions to Race-based and Personalized Medicine Vignettes: An Experimental Study
The Roles of Trust and Respect in Patient Reactions to Race-Based and Personalized Medicine Vignettes: An Experimental Study
Status: Enrolling
Updated:  9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
The Roles of Trust and Respect in Patient Reactions to Race-based and Personalized Medicine Vignettes: An Experimental Study
The Roles of Trust and Respect in Patient Reactions to Race-Based and Personalized Medicine Vignettes: An Experimental Study
Status: Enrolling
Updated: 9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
X-ray Fluoroscopy Fused With Computed Tomography (XFC) Technical Development
X-ray Fluoroscopy Fused With Computed Tomography (XFC) Technical Development
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
X-ray Fluoroscopy Fused With Computed Tomography (XFC) Technical Development
X-ray Fluoroscopy Fused With Computed Tomography (XFC) Technical Development
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Heart and Hands Study II: A Retrospective Data Collection & Analysis Project
Heart and Hands Study II: A Retrospective Data Collection & Analysis Project
Status: Enrolling
Updated:  9/28/2015
HealthEast Care System, Inc
mi
from
St. Paul, MN
Heart and Hands Study II: A Retrospective Data Collection & Analysis Project
Heart and Hands Study II: A Retrospective Data Collection & Analysis Project
Status: Enrolling
Updated: 9/28/2015
HealthEast Care System, Inc
mi
from
St. Paul, MN
Click here to add this to my saved trials
Improving Prevention of Heart Disease in Latinos
Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk
Status: Enrolling
Updated:  9/29/2015
Denver Health Medical Center
mi
from
Denver, CO
Improving Prevention of Heart Disease in Latinos
Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk
Status: Enrolling
Updated: 9/29/2015
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study
Improving Cardiovascular Risk Prediction Using Hand-Held Carotid Ultrasonography Study
Status: Enrolling
Updated:  9/29/2015
Internal Medicine and Pediatrics, S.C.
mi
from
Fort Atkinson, WI
Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study
Improving Cardiovascular Risk Prediction Using Hand-Held Carotid Ultrasonography Study
Status: Enrolling
Updated: 9/29/2015
Internal Medicine and Pediatrics, S.C.
mi
from
Fort Atkinson, WI
Click here to add this to my saved trials